IAVI

Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Scientific Publications

Geographic mobility and treatment outcomes among people in care for tuberculosis in the Lake Victoria region of East Africa: A multi-site prospective cohort study

Read more

Podcasts

Meet The Scientist Episode 1: Gabriela Gomez

June 1, 2023

In Amsterdam, we sat down with Gabriela Gomez, senior director of global access at IAVI, to discuss her work using modeling to understand the potential impact of a new tuberculosis (TB) vaccine. As the COVID-19 pandemic has waned, TB once again has become the leading infectious cause of death in much of the world. In 2021, an estimated 1.6 million people died as a result of TB disease, making a new TB vaccine all the more vital. Gabriela Gomez also uses modeling to better understand how a new TB vaccine can be developed and distributed in an equitable and accessible way.This podcast will explore the importance of epidemiology—a branch of medical science that investigates all the factors that determine the presence or absence of diseases—in TB vaccine R&D and global health access in general. Listen to the first episode of our new series Meet The Scientist to learn more about how IAVI is using epidemiology to develop affordable, globally accessible vaccines and antibodies.

Read more

In The News

Six HIV vaccines in research and development in the US, Rwanda, South Africa and Kenya

Daily Maverick

May 30, 2023

Read more

Features

Novel HIV vaccine candidate stimulates immune response in T cells

May 25, 2023

New analysis of IAVI G001 trial shows nanoparticle HIV vaccine creates strong immune response in helper T cells

Read more

Scientific Publications

A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses

Read more

IAVI Report

COVID-19 is no longer an emergency, but its lessons better linger

May 24, 2023

Two new books illustrate why reflection and preparation are both essential to ensure a quicker and more equitable response to the next pandemic.

Read more

Scientific Publications

Antibodies for HIV prevention: the path forward

Read more

Press Releases

Zendal and IAVI announce expanded agreement to partner on development of TB vaccine candidate MTBVAC

May 16, 2023

TB kills 1.6 million people a year, causing more deaths than any other single infectious disease apart from COVID-19, and sickens more than 10 million people annually. A new TB vaccine is needed to reach global END TB goals. MTBVAC is a highly promising vaccine candidate that has the potential to be used as an…

Read more